AVAC
@HIVpxresearch
Followers
16K
Following
10K
Media
5K
Statuses
22K
Proven strategies for today and research for tomorrow. A global source for updates, advocacy and information on HIV prevention.
New York, USA
Joined April 2010
@imglobalhealth @KFF @jenkatesdc @Srj_Madoori Given the increasing and alarming rise of misinformation on X, it is essential we find new ways to share accurate, science-based information. AVAC is beginning our transition to the platform Bluesky. 🦋 Make sure to follow us there!
0
1
12
RT @devex: Despite the changes in the global health funding landscape, AVAC (@HIVpxresearch) Executive Director Mitchell Warren highlights….
0
1
0
RT @mdoherty_hiv: Prevention is needed to #ENDAIDS .Freeze on global HIV prevention efforts sparks disbelief, anger | Science | AAAS https….
science.org
After chaotic halt, PEPFAR’s global distribution of HIV treatments may be resuming but limits on using drugs to curb viral spread remain
0
13
0
RT @Bhekisisa_MG: #DonaldTrump’s rule will almost certainly mean less money for the US government’s #Aids fund #Pepfar. SA has received R14….
0
2
0
One of the biggest news items of 2024 was the incredible effectiveness of injectable lenacapavir for #HIV prevention. But can the world translate this science into public health impact? Our Mitchell Warren and @JRatevosian think so — and explain how in this @devex commentary 👇.
There is hope for a new 5 by 3 global target of getting 5 million people on long-acting PrEP to prevent HIV by 2030.
2
2
11
Among his many contributions, #JimmyCarter was a pioneer in global health. A great summary from @snolen: — with this essential lesson for @melindagates
1
0
6
Advocating for #PrEP with speed, scale and equity will be an essential part of our work in 2025. Kick-off the year by bookmarking #PrEPWatch for the latest in research & development (R&D), implementation and #PrEP initiations worldwide. 🌐 Explore more at
0
9
19
RT @Bhekisisa_MG: #DonaldTrump’s rule will almost certainly mean less money for the US government’s #Aids fund #Pepfar. SA has received R14….
0
1
0
An op-ed on the potential of #LEN penned by AVAC's executive director Mitchell Warren and @JRatevosian in @devex, Gilead plans to halt free access to #HIV drug, worrying advocates, and more in the final #NewsDigest of 2024. 📰 Read on and subscribe!
0
0
8
Positive steps toward rolling #LEN for #PrEP out with speed, scale & equity, but more more needs to happen. ICYMI, @GileadSciences filed to US FDA and @PEPFAR & @GlobalFund announced a coordinated effort to reach 2M people with access to LEN. Read more:
0
8
20
RT @CarlosdelRio7: .@GileadSciences Submits New Drug Application to U.S. Food and Drug Administration for Twice-Yearly Lenacapavir for HIV….
0
20
0
RT @HIVpxresearch: Just released! 💥 #LEN, the twice-yearly injectable #PrEP has the potential to transform the #HIV response, but only if i….
0
4
0
Just released! 💥 #LEN, the twice-yearly injectable #PrEP has the potential to transform the #HIV response, but only if it is rolled out with speed, scale and equity. Read the latest op-ed from AVAC’s ED Mitchell Warren and @JRatevosian in @devex.
0
4
9
RT @Acts101U: Join us tonight as we assess 40 years of HIV response for Uganda, the challenges we have encountered and how we can do better….
0
7
0
@DukeU_Nursing Tonia Poteat of @DukeU_Nursing shares the important role peer navigators (PN) played in #HPTN091 including not only sharing information but resources (i.e. name changes, food stamps etc.). A sound bite from one of the PNs: "Together we are stronger than we imagine".
1
0
4
"Randomization works" 🎯 Tonia Poteat of @DukeU_Nursing breaks down the diverse characteristics of people enrolled in #HPTN091 and how important it was to include participants that would benefit most from #PrEP.
1
0
1
@DukeU_Nursing @HIVptn Tonia Poteat of @DukeU_Nursing discusses the real challenges trans people face when finding a service provider they trust. This challenge impacted how participated in #HPTN091. More below ⤵️
1
0
1